Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)

China · Delayed Price · Currency is CNY

66.38

+4.37 (7.05%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2015
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '15 Dec 31, 2015
Pharmaceuticals	1.33B	1.35B	1.12B	1.17B	1.02B
Pharmaceuticals Growth	-1.36%	20.82%	-4.56%	14.43%	10.96%
Total	1.33B	1.35B	1.12B	1.17B	1.02B
Total Growth	-1.36%	20.82%	-4.56%	14.43%	10.96%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '15 Dec 31, 2015
East China	505.58M	-	-	-
Northern China	199.57M	-	-	-
Southwest Region	270.65M	-	-	-
Southern China	160.29M	-	-	-
Central China Region	92.68M	-	-	-
Northeast China Region	59.19M	-	-	-
Northwestern Region	34.69M	-	-	-
Overseas Regions	25.26M	-	-	-
Total	1.35B	-	-	-

Source: S&P Global Market Intelligence.